EFFICACY OF METHOTREXATE ALONE OR WITH LOW-DOSE PREDNISONE IN ALOPECIA AREATA TOTALIS
نویسندگان
چکیده
This study aimed to evaluate the efficacy of methotrexate alone or in combination with low-dose prednisone treating alopecia areata totalis. A randomized controlled trial was conducted among 100 patients diagnosed Participants were randomly assigned two treatment groups: Group received alone, and B prednisone. The primary outcome measure proportion achieving hair regrowth at end period. Secondary outcomes included time regrowth, duration response, adverse events. Of patients, 50 B. findings revealed that both regimens, prednisone, showed promoting In A, 30 (60%) achieved while B, 40 (80%) regrowth. therapy group demonstrated a higher than methotrexate-alone group. for also shorter compared Adverse events minimal comparable between groups. results this suggest are effective options superior reducing alone. support use as potential approach However, further research larger sample size is warranted validate these establish optimal dosing long-term safety patient population.
منابع مشابه
Low-Dose Systemic Methotrexate Therapy for Recalcitrant Alopecia Areata
BACKGROUND Alopecia areata (AA) is an autoimmune skin disease difficult to manage and treat. The pathogenesis of AA features a T-cell-associated autoimmune process, and systemic immunosuppressive therapy is prescribed widely for AA. OBJECTIVE To evaluate the efficacy and tolerance of systemic low-dose methotrexate (LD-MTX) therapy in treatment of recalcitrant AA multiplex. METHODS In a retr...
متن کاملEfficacy and safety of methotrexate in alopecia areata*
BACKGROUND Alopecia areata is a chronic disorder of the hair follicles and nails, of unknown etiology, with clear autoimmune components and genetic factors. Several therapeutic options have been suggested; however, no treatment is able to modify the disease course. Methotrexate is an immunosuppressant used in various dermatoses and recently introduced as a therapeutic option for alopecia areata...
متن کاملEfficacy of topical immunotherapy of extensive and/or chronic Alopecia Areata with Diphencyprone
Background: Highly variable results of topical immunotherapy with Diphencyprone (DPC) in the treatment of Alopecia areata have been reported so far. Objective: The purpose of this study was to evaluate the efficacy and tolerability of DPC in the treatment of severe and chronic chronic Alopecia areata. Patients and Methods: 28 patients (16 female and 12 male, 10-35 years old, mean age 25 years) ...
متن کاملEfficacy of dinitrochlorobenzene in the treatment of alopecia areata
Background: Various kinds of sensitizers are administrated foralopecia areata treatment. The aim of this study was to evaluatetreatment response to Dinitrochlorobenzene (DNCB) in alopeciaareata patients.Method: In this study, 117 patients were treated with DNCBunder a specific checklist. All patients were sensitized with a 2%DNCB and then treated with ascending DNCB concentrations(0.001%-2%). R...
متن کاملEfficacy of Topical Diphencyprone in the Treatment of Alopecia Areata
Background: Topical immunotherapy with diphencyprone (DPCP) for the treatment of severe alopecia areata has been used since 1983 and is felt to be the treatment of choice for chronic extensive alopecia areata. Highly variable results have been reported. The purposes of this study were to evaluate the efficacy of DPCP in the treatment of chronic, extensive alopecia areata and to assess the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biological & clinical sciences research journal
سال: 2023
ISSN: ['2708-2261']
DOI: https://doi.org/10.54112/bcsrj.v2023i1.332